Vascular Endothelial Growth Factor (VEGF) Gene Polymorphisms and Breast Cancer Risk in a Chinese Population |
Luo, Ting
(Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University)
Chen, Long (Department of Laboratory Medicine, West China Hospital, Sichuan University) He, Ping (Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University) Hu, Qian-Cheng (Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University) Zhong, Xiao-Rong (Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University) Sun, Yu (Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University) Yang, Yuan-Fu (Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University) Tian, Ting-Lun (Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University) Zheng, Hong (Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University) |
1 | Bae SJ, Ahn DH, Hong SP, et al (2008). Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J, 49, 783-91. DOI ScienceOn |
2 | Belinsky GS, Claffey KP, Nambiar PR, et al (2005). Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line. Mol Carcinog, 43, 65-74. DOI ScienceOn |
3 | Dassoulas K, Gazouli M, Rizos S, et al (2009). Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog, 48, 563-9. DOI ScienceOn |
4 | Eroglu A, Ozturk A, Cam R, et al (2008). Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. Med Oncol, 25, 54-5. DOI ScienceOn |
5 | Ferrara N (2002). VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer, 2, 795-803. DOI ScienceOn |
6 | Ferrara N, Gerber HP, LeCouter J (2003). The biology of VEGF and its receptors. Nat Med, 9, 669-76. DOI ScienceOn |
7 | Garcia-Closas M, Malats N, Real FX, et al (2007). Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet, 3, e29. DOI ScienceOn |
8 | Gu D, Wang M (2011). VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls. Breast Cancer Res Treat, 125, 489-93. DOI |
9 | Iordache S, Saftoiu A, Georgescu CV, et al (2010). Vascular endothelial growth factor expression and microvessel density-two useful tools for the assessment of prognosis and survival in gastric cancer patients. J Gastrointestin Liver Dis, 19, 135-9. |
10 | Jacobs EJ, Feigelson HS, Bain EB, et al (2006). Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res, 8, R22. DOI ScienceOn |
11 | Jakubowska A, Gronwald J, Menkiszak J, et al (2008). The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett, 262, 71-6. DOI ScienceOn |
12 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
13 | Jin B, Jiang F, Ding Z (2011). Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk. Breast Cancer Res Treat, 128, 909-12. DOI ScienceOn |
14 | Jin Q, Hemminki K, Enquist K, et al (2005). Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res, 11, 3647-53. DOI ScienceOn |
15 | Lee SJ, Lee SY, Jeon HS, et al (2005). Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev, 14, 571-5. DOI ScienceOn |
16 | Kataoka N, Cai Q, Wen W, et al (2006). Population-based casecontrol study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev, 15, 1148-52. DOI ScienceOn |
17 | Krippl P, Langsenlehner U, Renner W, et al (2003). A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer, 106, 468-71. DOI ScienceOn |
18 | Langsenlehner U, Wolf G, Langsenlehner T, et al (2008). Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study. Breast Cancer Res Treat, 109, 297-304. DOI |
19 | Liu L, Hua FZ, Cao JQ, et al (2011). VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification. Breast Cancer Res Treat, 127, 569-71. DOI |
20 | Lu H, Shu XO, Cui Y, et al (2005). Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res, 65, 5015-9. DOI ScienceOn |
21 | Oliveira C, Lourenco GJ, Silva PM, et al (2011). Polymorphisms in the 5'-and 3'-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics. Tumour Biol, 32, 295-300. DOI ScienceOn |
22 | Perrone G, Vincenzi B, Santini D, et al (2004). Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancer. Cancer Lett, 208, 227-34. DOI ScienceOn |
23 | Ronco AL, De Stefani E, Deneo-Pellegrini H (2012a). Risk factors for premenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 2879-86. DOI ScienceOn |
24 | Qiu LX, Wang K, Yang S, et al (2011). Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility. Mol Biol Rep, 38, 4491-4. DOI |
25 | Renner W, Kotschan S, Hoffmann C, et al (2000). A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res, 37, 443-8. DOI ScienceOn |
26 | Rodrigues P, Furriol J, Tormo E, et al (2012). The singlenucleotide polymorphisms +936 C/T VEGF and-710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population. Breast Cancer Res Treat, 133, 769-78. DOI ScienceOn |
27 | Ronco AL, De Stefani E, Deneo-Pellegrini H, et al (2012b). Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 139-46. DOI ScienceOn |
28 | Roy H, Bhardwaj S, Yla-Herttuala S (2006). Biology of vascular endothelial growth factors. FEBS Lett, 580, 2879-87. DOI ScienceOn |
29 | Schneider BP, Wang M, Radovich M, et al (2008). Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol, 26, 4672-8. DOI ScienceOn |
30 | Shamsi U, Khan S, Usman S, et al (2013). A multicenter matched case control study of breast cancer risk factors among women in Karachi, Pakistan. Asian Pac J Cancer Prev, 14, 183-8. DOI ScienceOn |
31 | Wang K, Li X, Zhou C, et al (2013). Socio-economic Factors Influencing Tumor Presentation and Treatment Options in Chinese Breast Cancer Patients. Asian Pac J Cancer Prev, 14, 267-74. DOI ScienceOn |
32 | Stefanou D, Batistatou A, Kamina S, et al (2004). Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo, 18, 155-60. |
33 | Sun JW, Li XR, Gao HY, et al (2013). Electromagnetic Field Exposure and Male Breast Cancer Risk: A Meta-analysis of 18 Studies. Asian Pac J Cancer Prev, 14, 523-8. DOI ScienceOn |
34 | Vincenti V, Cassano C, Rocchi M, et al (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation, 93, 1493-5. DOI ScienceOn |
35 | Wang K, Liu L, Zhu ZM, et al (2011). Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals. Cytokine, 56, 167-73. DOI ScienceOn |
36 | Wang K, Peng HL, Li LK (2012). Prognostic value of vascular endothelial growth factor expression in patients with prostate cancer: a systematic review with meta-analysis. Asian Pac J Cancer Prev, 13, 5665-9. DOI ScienceOn |
37 | Watson CJ, Webb NJ, Bottomley MJ, et al (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine, 12, 1232-5. DOI ScienceOn |
38 | Wehrschuetz M, Schollnast H, Wehrschuetz E, et al (2009). VEGF 936C > T polymorphism and association of BI-RADS score in women with suspected breast cancer. Breast Cancer (Auckl), 3, 77-81. |
39 | Yang DS, Park KH, Woo OH, et al (2011). Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 125, 849-53. DOI |
40 | Zhang YF, Kang HB, Li BL, et al (2012). Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev, 13, 479-82. DOI ScienceOn |
41 | Zhou LP, Luan H, Dong XH, et al (2012a). Association between XRCC5, 6 and 7 gene polymorphisms and the risk of breast cancer: a HuGE review and meta-analysis. Asian Pac J Cancer Prev, 13, 3637-43. DOI ScienceOn |
42 | Zhou P, Huang W, Chu X, et al (2012b). The lymphotoxin-alpha 252A>G polymorphism and breast cancer: a meta-analysis. Asian Pac J Cancer Prev, 13, 1949-52. DOI ScienceOn |
43 | Zhou Y, Li N, Zhuang W, et al (2011). Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. Mol Carcinog, 50, 184-8. DOI ScienceOn |